Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations

IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES International Journal of Infectious Diseases Pub Date : 2024-08-06 DOI:10.1016/j.ijid.2024.107198
Xue-Dong Song , Guo-Jian Yang , Chao Shi , Xiao-Lin Jiang , Xue-Jun Wang , Yu-Wei Zhang , Jie Wu , Lian-Xiang Zhao , Ming-Ming Wang , Rui-Rui Chen , Xue-Juan He , Er-Hei Dai , Yuan Shen , Hui-Xia Gao , Gang Dong , Mai-Juan Ma
{"title":"Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations","authors":"Xue-Dong Song ,&nbsp;Guo-Jian Yang ,&nbsp;Chao Shi ,&nbsp;Xiao-Lin Jiang ,&nbsp;Xue-Jun Wang ,&nbsp;Yu-Wei Zhang ,&nbsp;Jie Wu ,&nbsp;Lian-Xiang Zhao ,&nbsp;Ming-Ming Wang ,&nbsp;Rui-Rui Chen ,&nbsp;Xue-Juan He ,&nbsp;Er-Hei Dai ,&nbsp;Yuan Shen ,&nbsp;Hui-Xia Gao ,&nbsp;Gang Dong ,&nbsp;Mai-Juan Ma","doi":"10.1016/j.ijid.2024.107198","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the effects of repeated vaccination with ancestral SARS-CoV-2 (Wuhan-hu-1)-based inactivated, recombinant protein subunit or vector-based vaccines on the neutralizing antibody response to Omicron subvariants.</p></div><div><h3>Methods</h3><p>Individuals who received four-dose vaccinations with the Wuhan-hu-1 strain, individuals who were infected with the BA.5 variant alone without prior vaccination, and individuals who experienced a BA.5 breakthrough infection (BTI) following receiving 2-4 doses of the Wuhan-hu-1 vaccine were enrolled. Neutralizing antibodies against D614G, BA.5, XBB.1.5, EG.5.1, and BA.2.86 were detected using a pseudovirus-based neutralization assay. Antigenic cartography was used to analyze cross-reactivity patterns among D614G, BA.5, XBB.1.5, EG.5.1, and BA.2.86 and sera from individuals.</p></div><div><h3>Results</h3><p>The highest neutralizing antibody titers against D614G were observed in individuals who only received four-dose vaccination and those who experienced BA.5 BTI, which was also significantly higher than the antibody titers against XBB.1.5, EG.5.1, and BA.2.86. In contrast, only BA.5 infection elicited comparable neutralizing antibody titers against the tested variants. While neutralizing antibody titers against D614G or BA.5 were similar across the cohorts, the neutralizing capacity of antibodies against XBB.1.5, EG.5.1, and BA.2.86 was significantly reduced. BA.5 BTI following heterologous booster induced significantly higher neutralizing antibody titers against the variants, particularly against XBB.1.5 and EG.5.1, than uninfected vaccinated individuals, only BA.5 infected individuals, or those with BA.5 BTI after primary vaccination.</p></div><div><h3>Conclusions</h3><p>Our findings suggest that repeated vaccination with the Wuhan-hu-1 strain imprinted a neutralizing antibody response toward the Wuhan-hu-1 strain with limited effects on the antibody response to the Omicron subvariants.</p></div>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.8000,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1201971224002698/pdfft?md5=82d21d1715e88101d0f2a73f83cb99b8&pid=1-s2.0-S1201971224002698-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1201971224002698","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

To investigate the effects of repeated vaccination with ancestral SARS-CoV-2 (Wuhan-hu-1)-based inactivated, recombinant protein subunit or vector-based vaccines on the neutralizing antibody response to Omicron subvariants.

Methods

Individuals who received four-dose vaccinations with the Wuhan-hu-1 strain, individuals who were infected with the BA.5 variant alone without prior vaccination, and individuals who experienced a BA.5 breakthrough infection (BTI) following receiving 2-4 doses of the Wuhan-hu-1 vaccine were enrolled. Neutralizing antibodies against D614G, BA.5, XBB.1.5, EG.5.1, and BA.2.86 were detected using a pseudovirus-based neutralization assay. Antigenic cartography was used to analyze cross-reactivity patterns among D614G, BA.5, XBB.1.5, EG.5.1, and BA.2.86 and sera from individuals.

Results

The highest neutralizing antibody titers against D614G were observed in individuals who only received four-dose vaccination and those who experienced BA.5 BTI, which was also significantly higher than the antibody titers against XBB.1.5, EG.5.1, and BA.2.86. In contrast, only BA.5 infection elicited comparable neutralizing antibody titers against the tested variants. While neutralizing antibody titers against D614G or BA.5 were similar across the cohorts, the neutralizing capacity of antibodies against XBB.1.5, EG.5.1, and BA.2.86 was significantly reduced. BA.5 BTI following heterologous booster induced significantly higher neutralizing antibody titers against the variants, particularly against XBB.1.5 and EG.5.1, than uninfected vaccinated individuals, only BA.5 infected individuals, or those with BA.5 BTI after primary vaccination.

Conclusions

Our findings suggest that repeated vaccination with the Wuhan-hu-1 strain imprinted a neutralizing antibody response toward the Wuhan-hu-1 strain with limited effects on the antibody response to the Omicron subvariants.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过重复接种疫苗,对 Omicron 亚变体的中和抗体反应产生有限的免疫印记。
目的研究重复接种以 SARS-CoV-2(武汉-胡-1)为基础的灭活疫苗、重组蛋白亚单位疫苗或载体疫苗对 Omicron 亚变异株中和抗体反应的影响:研究对象包括接种四剂武汉-湖北-1 株疫苗的个体、未接种疫苗而单独感染 BA.5 变异株的个体,以及接种 2-4 剂武汉-湖北-1 株疫苗后出现 BA.5 突破性感染的个体。使用基于假病毒的中和试验检测了针对D614G、BA.5、XBB.1.5、EG.5.1和BA.2.86的中和抗体。使用抗原制图分析了 D614G、BA.5、XBB.1.5、EG.5.1 和 BA.2.86 与个体血清之间的交叉反应模式:只接种了四剂疫苗和经历过 BA.5 突破性感染的人对 D614G 的中和抗体滴度最高,也明显高于对 XBB.1.5、EG.5.1 和 BA.2.86 的抗体滴度。相比之下,只有 BA.5 感染才会引起与受测变体相当的中和抗体滴度。虽然针对D614G或BA.5的中和抗体滴度在各组群中相似,但针对XBB.1.5、EG.5.1和BA.2.86的中和抗体能力却明显下降。与未感染疫苗的个体、仅感染 BA.5 的个体或初次接种后突破性感染 BA.5 的个体相比,异源加强免疫后 BA.5 突破性感染引起的针对变体的中和抗体滴度明显更高,尤其是针对 XBB.1.5 和 EG.5.1 的抗体滴度:我们的研究结果表明,重复接种武汉-湖-1 株疫苗会产生针对武汉-湖-1 株的中和抗体反应,而对奥米克龙亚变异株的抗体反应影响有限。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
18.90
自引率
2.40%
发文量
1020
审稿时长
30 days
期刊介绍: International Journal of Infectious Diseases (IJID) Publisher: International Society for Infectious Diseases Publication Frequency: Monthly Type: Peer-reviewed, Open Access Scope: Publishes original clinical and laboratory-based research. Reports clinical trials, reviews, and some case reports. Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases. Emphasizes diseases common in under-resourced countries.
期刊最新文献
Kinetics of Hepatitis B Virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to Tenofovir sparing therapy. Non-pharmaceutical interventions to reduce influenza transmission in households: a systematic review and meta-analysis. Preventing central line-associated bloodstream infections: A position paper of the International Society for Infectious Diseases, 2024 update. Total burden of hepatitis B and C attributed to injecting drug use in 204 countries and territories from 1990 to 2021: Analyses based on the Global Burden of Disease Study 2021. Microbiological Aspects and Clinical Impact of Lower Lung Field Tuberculosis: an Observational Cohort Study in Peru.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1